Alphaform Ag (AFRMF) 0.0365 $AFRMF Proto Labs c
Post# of 273319
Posted On: 09/20/2016 3:05:06 AM
Alphaform Ag (AFRMF) 0.0365 $AFRMF
Proto Labs closes acquisition of certain assets and operation of Alphaform AG in Germany
M2 - Mon Oct 12, 5:51AM CDT
Proto Labs Inc (NYSE: PRLB) announced on Friday that it has completed the purchase of select assets and operations of German-based manufacturer Alphaform AG, a service bureau headquartered in Feldkirchen (Munich), Germany.
PRLB: 56.33 (+1.80)
Proto Labs to accelerate growth of additive manufacturing services in Europe through acquisition of Alphaform AG
M2 - Fri Sep 25, 6:39AM CDT
Digital manufacturing company Proto Labs (NYSE
RLB) said on Thursday that it has reached agreement in principle to acquire select assets and operations of Alphaform AG headquartered in Feldkirchen, Munich, Germany.
PRLB: 56.33 (+1.80)
Proto Labs to Acquire Alphaform AG
BusinessWire - Thu Sep 24, 12:00AM CDT
Proto Labs, Inc. (NYSE RLB) today announced that it has reached agreement in principle to acquire select assets and operations of Alphaform, AG subject to standard terms and conditions of purchase.
PRLB: 56.33 (+1.80)
3D Printing in Healthcare Market 2014-2020 - Role and Opportunities
M2 - Wed Sep 09, 3:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v3442f/3d_printing_in) has announced the addition of the "3D Printing in Healthcare Market (2014-2020):Role and Opportunities: By Technology (LBM, EBM, Stereolithography and others); By Material (Metal, Cells and others); By Application (Implants, Tissue Engineering and others) & By Geography" report to their offering. The global market for 3D printing was dominated by aerospace and automobile industry. However, the medical and healthcare industry is projected to exhibit the highest growth rate due to the high amounts of government funding being allocated for these technologies. The increasing demand for custom-made medical products such as tissues, orthopedic and dental implants, prosthetic devices, medicines and so on is expected to drive the demand for 3D printing technology in healthcare and medicine. The market is set to be driven by the increasing demand for patient-specific tailored products in orthopedics and maxillofacial surgery. Advances in tissue engineering for 3D bio-printing is gaining importance and the tissues generated by bio-printing will be available for transplant in the near future. However, high costs and regulatory barriers are likely to hinder the market growth. Americas exhibited the highest market share exceeding 37% of the global 3D printing in healthcare market in 2014 due to the high funding for research activities in this area, enhanced health consciousness among patients and increased spending on healthcare. On the other hand, Europe is poised to grow with the highest annual growth rate during the period under study. The high growth can be attributed to the rising demand for customized or personalized implants or prosthetic devices and medicines suited for an individual's needs. Huge number of research programs and increasing funds for the same are expected to drive the market in this region. Key Topics Covered: 1 Executive Summary 2 Global 3D Printing in Healthcare - Market Overview 3 Market Landscape 4 3D Printing in Healthcare Market - Market Forces 5 Global 3d Printing in Healthcare Market - Strategic Analysis 6 Global 3D Printing in Healthcare Market - By Technology 7 Global 3D Printing in Healthcare Market - By Material 8 Global 3D Printing in Healthcare Market - By Application 9 By Geography 10 Company Profiles - Javelin Technologies Inc. - Medical Modeling Inc. - Nano3D Biosciences Inc. - Tissue Regeneration Systems Inc. - Xilloc Medical - D Biotek Llc. - T RPD Ltd. - Alphaform Ag - Organovo Holdings Inc. - Beltone A/S - Gyrobot Limited - Stryker Corporation - D Systems - Stratasys Ltd. - Arcam - Envisiontec Gmbh - EOS GMBH Electro Optical Systems - Materialise N.V. - Oxford Performance Materials - Tethon 3D For more information visit http://www.researchandmarkets.com/research/v3...rinting_in
ONVO: 4.02 (-0.03), SSYS: 22.00 (+0.29), SYK: 114.42 (+0.10)
Proto Labs closes acquisition of certain assets and operation of Alphaform AG in Germany
M2 - Mon Oct 12, 5:51AM CDT
Proto Labs Inc (NYSE: PRLB) announced on Friday that it has completed the purchase of select assets and operations of German-based manufacturer Alphaform AG, a service bureau headquartered in Feldkirchen (Munich), Germany.
PRLB: 56.33 (+1.80)
Proto Labs to accelerate growth of additive manufacturing services in Europe through acquisition of Alphaform AG
M2 - Fri Sep 25, 6:39AM CDT
Digital manufacturing company Proto Labs (NYSE
RLB) said on Thursday that it has reached agreement in principle to acquire select assets and operations of Alphaform AG headquartered in Feldkirchen, Munich, Germany. PRLB: 56.33 (+1.80)
Proto Labs to Acquire Alphaform AG
BusinessWire - Thu Sep 24, 12:00AM CDT
Proto Labs, Inc. (NYSE
RLB) today announced that it has reached agreement in principle to acquire select assets and operations of Alphaform, AG subject to standard terms and conditions of purchase. PRLB: 56.33 (+1.80)
3D Printing in Healthcare Market 2014-2020 - Role and Opportunities
M2 - Wed Sep 09, 3:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v3442f/3d_printing_in) has announced the addition of the "3D Printing in Healthcare Market (2014-2020):Role and Opportunities: By Technology (LBM, EBM, Stereolithography and others); By Material (Metal, Cells and others); By Application (Implants, Tissue Engineering and others) & By Geography" report to their offering. The global market for 3D printing was dominated by aerospace and automobile industry. However, the medical and healthcare industry is projected to exhibit the highest growth rate due to the high amounts of government funding being allocated for these technologies. The increasing demand for custom-made medical products such as tissues, orthopedic and dental implants, prosthetic devices, medicines and so on is expected to drive the demand for 3D printing technology in healthcare and medicine. The market is set to be driven by the increasing demand for patient-specific tailored products in orthopedics and maxillofacial surgery. Advances in tissue engineering for 3D bio-printing is gaining importance and the tissues generated by bio-printing will be available for transplant in the near future. However, high costs and regulatory barriers are likely to hinder the market growth. Americas exhibited the highest market share exceeding 37% of the global 3D printing in healthcare market in 2014 due to the high funding for research activities in this area, enhanced health consciousness among patients and increased spending on healthcare. On the other hand, Europe is poised to grow with the highest annual growth rate during the period under study. The high growth can be attributed to the rising demand for customized or personalized implants or prosthetic devices and medicines suited for an individual's needs. Huge number of research programs and increasing funds for the same are expected to drive the market in this region. Key Topics Covered: 1 Executive Summary 2 Global 3D Printing in Healthcare - Market Overview 3 Market Landscape 4 3D Printing in Healthcare Market - Market Forces 5 Global 3d Printing in Healthcare Market - Strategic Analysis 6 Global 3D Printing in Healthcare Market - By Technology 7 Global 3D Printing in Healthcare Market - By Material 8 Global 3D Printing in Healthcare Market - By Application 9 By Geography 10 Company Profiles - Javelin Technologies Inc. - Medical Modeling Inc. - Nano3D Biosciences Inc. - Tissue Regeneration Systems Inc. - Xilloc Medical - D Biotek Llc. - T RPD Ltd. - Alphaform Ag - Organovo Holdings Inc. - Beltone A/S - Gyrobot Limited - Stryker Corporation - D Systems - Stratasys Ltd. - Arcam - Envisiontec Gmbh - EOS GMBH Electro Optical Systems - Materialise N.V. - Oxford Performance Materials - Tethon 3D For more information visit http://www.researchandmarkets.com/research/v3...rinting_in
ONVO: 4.02 (-0.03), SSYS: 22.00 (+0.29), SYK: 114.42 (+0.10)
(0)
(0)